Purple Biotech Ltd. Logo

Purple Biotech Ltd.

PPBT | TA

Overview

Corporate Details

ISIN(s):
IL0007650166
LEI:
Country:
Israel
Address:
Oppenheimer 4, 7670104 Rehovot
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company's core focus is on overcoming tumor immune evasion and drug resistance by targeting the tumor microenvironment (TME). Its pipeline features innovative treatments designed to provide effective and durable therapeutic outcomes. Formerly known as Kitov Pharma Ltd., Purple Biotech actively expands its portfolio, including through the acquisition of Immunorizon and its portfolio of tri-specific antibodies, to advance its mission of developing novel oncology treatments.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Purple Biotech Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-04 18:29
Share Issue/Capital Change
Announces Pricing of Up To $18 Million Public Offering
English 148.1 KB
2025-09-04 18:29
Foreign Filer Report
Announces Pricing of Up To $18 Million Public Offering
English 36.6 KB
2025-09-04 16:19
Foreign Filer Report
Announces New Data Supporting the Unique Design of CAPTN-3
English 185.3 KB
2025-09-04 16:19
Foreign Filer Report
Announces New Data Supporting the Unique Design of CAPTN-3
English 36.6 KB
2025-09-04 16:18
Regulatory News Service
Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3
English 214.8 KB
2025-09-04 16:18
Foreign Filer Report
Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3
English 36.6 KB
2025-09-03 16:15
Foreign Filer Report
Purple Biotech Expands CAPTN-3 Portfolio-PR
English 36.6 KB
2025-09-03 16:13
Foreign Filer Report
Purple Biotech Expands CAPTN-3 Portfolio
English 164.4 KB
2025-09-03 16:13
Foreign Filer Report
Purple Biotech Expands CAPTN-3 Portfolio
English 36.6 KB
2025-08-27 16:16
Regulatory News Service
Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investm…
English 154.4 KB
2025-08-27 16:16
Foreign Filer Report
Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investm…
English 36.5 KB
2025-08-06 16:10
Foreign Filer Report
Purple Biotech Reports Second Quarter 2025 Financial Results
English 275.0 KB
2025-08-06 16:10
Foreign Filer Report
Purple Biotech Reports Second Quarter 2025 Financial Results
English 36.9 KB
2025-07-23 16:11
Foreign Filer Report
6K: Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Prog…
English 196.4 KB
2025-07-23 16:11
Foreign Filer Report
6K: Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Prog…
English 36.8 KB

Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN